Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000221744 | SCV000275389 | likely benign | Hereditary cancer-predisposing syndrome | 2015-04-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000226195 | SCV000284440 | likely benign | Neurofibromatosis, type 1 | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001175017 | SCV001338533 | likely benign | not specified | 2020-04-17 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000221744 | SCV002527530 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-12-28 | criteria provided, single submitter | curation |